Believe in a Better Way
About WINFertility and RGI.
For over 20 years, WINFertility has been the leading fertility solutions company and a trusted source to patients, providers and payers, making high quality fertility treatment and medication available to more people.
RGI, the world-renowned founder of PGD technology now offers the latest in cutting edge genetic testing solutions to WINFertility patients and practices, reducing the cost barrier to achieving improved success rates for IVF and the delivery of healthy babies for those with single gene disorders.
The RGI Story.
Recognized Leader in Genetics Testing From the Very BeginningDr. Yury Verlinsky was the founding father of Preimplantation Genetic Diagnosis and embryo analysis prior to in-vitro fertilization. Verlinsky used his polar body biopsy technique to first detect potential genetic defects in offspring.
Dr. Verlinsky established an International network of Centers in this field and became the founder of the Preimplantation Genetics Diagnosis International Society (PGDIS). Due to his research, Reproductive Genetic Innovations (RGI) became recognized as the leading genetics laboratory for the prevention of genetic disease through PGD. In fact, many of today’s geneticists studied under Dr. Verlinsky, helping to spread the utilization of this life-changing breakthrough.
Continuing the Legacy…The World-Renowned RGI Clinical Team
One of the first employees of RGI was Dr. Svetlana Rechitsky, PhD who joined Dr. Verlinsky in Chicago in 1989. Dr. Rechitsky serves as the President of RGI where she continues to head the molecular and IVF laboratories, performing the largest preimplantation genetic diagnosis (PGD) series for single gene disorders, the majority of the tests created at RGI for the first time. She has published more than 60 papers in the field of PGD, includingkey contributions to the Atlas of Preimplantation Genetic Diagnosis. Dr. Rechitsky serves also the serves as the President of the Preimplantation Genetics Diagnosis International Society.
Dr. Anver Kuliev, MD, PhD Dr. Anver Kuliev serves RGI as their Research Director. He received his PhD in Clinical Cytogenetics in 1969. From 1979, he was head of the World Health Organization (WHO)'s Hereditary Diseases Program in Geneva, where he developed the community-based programs for prevention of genetic disorders and early approaches for prenatal diagnosis. He moved to Reproductive Genetics Institute, Chicago, in 1990, where he headed the WHO Collaborating Center for Prevention of Genetic Disorders, and scientific research in prenatal and preimplantation genetics. He is an author of 200 papers, including 11 books in the aforementioned areas, as well as 5 books in the field of Preimplantation Genetics.
Dr. Joe Leigh Simpson, MD, FACOG, FACMG Dr. Joe Leigh Simpson, MD, FACOG, FACMG is the Clinical Director of RGI's PGD program. He received his undergraduate and medical education at Duke University (M.D., 1968), and postgraduate training at Cornell University Medical College. He is Past President of the Preimplantation Genetic Diagnosis International Society and Past President of the American Society Reproductive Medicine. He is President Elect of International Federation Fertility Society. Prior academic positions have included Northwestern University, (Professor and Head, Section of Human Genetics), University of Tennessee Memphis, (Chairman OB/GYN), Baylor College of Medicine, (Chairman, OB/GYN) and Florida International University (Executive Associate Dean for Academic Affairs). He retains appointments at Florida International. He is certified by the American Board of Medical Genetics as well as the American Board of Obstetrics and Gynecology.
Dr. Simpson has played leadership roles in many other professional organizations. These include, President of International Society of Prenatal Diagnosis, President of the Society for Gynecologic Investigation and President of the American College of Medical Genetics. He is a member of the U.S. National Academy of Sciences, Institute of Medicine (IOM). He currently serves as Senior Vice President of Research and Global Programs for the March of Dimes Foundation.
Dr. Simpson has written 15 major books and over 750 articles and chapters. His research has been funded by National Institutes of Health and other organizations. He remains active in many areas of prenatal genetic diagnosis and reproductive genetics, not only preimplantation genetic diagnosis but recovering cell free DNA and fetal cells from maternal blood.
Dr. Lee P. Shulman, MD, FACOG. FACMG Dr. Lee P Shulman is the medical director of RGI’s PGD program. Dr. Lee P. Shulman, MD is the Anna Ross Lapham Professor in Obstetrics and Gynecology and Chief of the Division of Reproductive Genetics at the Feinberg School of Medicine. He is a Fellow of the American College of Obstetricians and Gynecologists, a Founding Fellow of the American College of Medical Genetics and a Founding Member of the Society of Family Planning. Dr. Shulman graduated from Cornell University as well as Cornell University Medical College. Dr. Shulman completed residency in Obstetrics and Gynecology at North Shore University Hospital - Cornell University Medical College followed by a fellowship in Reproductive Genetics at the University of Tennessee, Memphis and then joined the Ob/Gyn faculty of the University of Tennessee, Memphis, becoming the Director of Reproductive Genetics in 1994. In 1999 he relocated to the University of Illinois at Chicago where he served as Deputy Head of the Department of Obstetrics and Gynecology, Director of the Divisions of Reproductive Genetics and Ambulatory Care Services and as Medical Director of the Center of Excellence in Women's Health.
Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women. He currently serves as the Immediate Past Chair of the Board of Trustees of the Association of Reproductive Health Professionals. His work has been recognized regionally and nationally. He is the Editor-in-Chief of the Yearbook of Obstetrics and Gynecology and Reproductive Medicine, is a Contributing Editor for The Journal of Reproductive Medicine and the Executive Editor of the Journal of Gynecologic Surgery. He also serves on the editorial boards of Contraception, Prenatal Diagnosis, Journal of Pediatric and Adolescent Gynecology, Menopause, and as a peer-reviewer for 31 journals. His major research interests are in reproductive and cancer genetics, contraception, botanical interventions in women's health and menopause.